Richard Motley's response assumes that, like supply, the demand for surgery is finite. This is clearly not the case. Despite a large increase in the number of surgeons, and a commensurate increase in the number of operations carried out in England over the past three decades, waiting lists have altered little. The phenomenon of the amount of supply being a key determinant of the level of demand can also be seen in comparisons with the US, where much higher provision of services results in surgical rates approximately twice those in the UK. This is why current 309
Dr Butterworth (March 2004 JRSM 1 ) describes how a relative of his was diagnosed as hypertensive and put on a succession of medicines with near disastrous consequences. This chain of events had nothing to do with the vogue for evidence-based medicine. Rather, it reflects the enormous difficulty of practising good and safe medicine in the era of effective but dangerous drugs. The proliferation of lifeprolonging as opposed to symptom-reducing drugs makes clinical medicine complex and time consuming-though no-one would guess this from the mass of guidelines and protocols and the devolution of traditional medical tasks to non-doctors, all based on a fundamentally faulty world view where everything is either right or wrong, good or bad, black or white. Such reductionist inanity now extends to assessments of massive hospitals or even the whole NHS.
It was not what clinical trials have told us about treating hypertension that poisoned Dr Butterworth's relative. Whether he met any standard criteria for hypertension requiring drug treatment is not clear. To treat consequent dizziness with another drug appears simply crass; life, however, is complex, and we do not know the patient's blood pressure at the time this decision was made. Undertreated as well as over-treated hypertension can cause dizziness. The wise old general practitioner who took him off all medications may well have saved this man, but for all we know has over the years missed the opportunity to prevent dozens of strokes by adopting a 'common sense' approach to the management of hypertension in the asymptomatic elderly. Common sense, like evidence-based medicine, should be used only when appropriate.
Thank goodness we live in the era of dangerous and powerful drugs. Though the public may think that brain surgeons or heart surgeons have the most challenging jobs in medicine, in future the most difficult tasks will be polypharmacy in the elderly with multiple medical problems, to achieve the best combination of wellbeing and longevity. To master those arts will require lifelong education, natural empathy and most importantly, time and desire to think before prescribing. It is not the concept of evidence-based medicine we need fear, it is that of immediately demonstrable value for money. Dr Shah and Dr Dawson's dilemma (March 2004 JRSM 1 ) of managing intracerebral haemorrhage (ICH) in a patient previously anticoagulated for a prosthetic heart valve will be familiar to many clinicians. Whilst re-anticoagulation would be current practice, this is based on perceptions that the benefits of thromboembolism prevention surpass the risks of re-haemorrhage. 2 Such decisions are prone to recall or availability bias, given the varying risks of valve thromboembolism and the fragmentary evidence base on risks of rebleeding with further antithrombotics/anticoagulants. Clinical trials are unlikely to resolve this dilemma, not least because of the difficulty of recruiting sufficient participants. Decision analysis presents an alternative solution-developing a framework in which to combine variations in multiple probabilities within a mathematical model. Such techniques allow examination of current practices where no consensus exists, using a range of values/scenarios to test the feasibility of the model. These techniques have already seen successful use in reexamining evidence-based guidelines and in assessing decision-making in atrial fibrillation and intracerebral haemorrhage. 3, 4 We are currently constructing a decision model to explore the dilemma faced by Shah and Dawson, testing the effects of using anticoagulants and antiplatelet agents in patients with mechanical valves and ICH. A key test of decision modelling outcomes is to review them against current practices, and it is noteworthy that recent case reports have highlighted the potential short-term use of antiplatelet agents such as aspirin and clopidogrel in place of immediate anticoagulation following cerebral bleeding. 5 Firstly, the terminology used in their article needs clarification. The valve in their case report is presumably mechanical, as it is described as 'bileaflet' and the references cited apply to mechanical valves only. The term 'metallic valve', used in the comment section, is best avoided since most mechanical valves are nowadays largely ceramic.
Secondly, although we agree that there is not a large amount of guidance on the management of intracranial bleeds in patients with mechanical valves, there are some useful papers specifically addressing this subject. In a review of the published work Crawley et al. 2 recommend full reversal of the coagulopathy with vitamin K and fresh frozen plasma, or with a prothrombin complex concentrate containing factors VII, II, IX and X. They identify the first 24 hours after an intracranial bleed as the most important time for correcting coagulopathy, since 50% of bleeds in anticoagulated patients continue to evolve over this time period, compared with only 10% of bleeds in nonanticoagulated patients. They conclude that the decision whether to restart warfarin should be based on the patient's risk of thromboembolism (which they calculate at 0.016% per day) versus the risk of further intracranial bleeding. Wijdicks et al. 3 followed up 39 patients with mechanical heart valves who had their anticoagulation reversed after intracranial haemorrhage. No patient experienced an embolic event during reversal, or a further intracranial bleed after reintroduction of oral anticoagulants during the hospital period. These workers conclude that oral anticoagulation should be discontinued for 1 to 2 weeks in these patients, if there is no previous evidence of systemic embolization. Admittedly, a minority of patients might then undergo surgery for conditions which would have resolved spontaneously, but the majority would be appropriately treated and without delay. The proposal that surgeons with private practice contrive to maintain long NHS waiting lists is offensive to hard-working members of the medical profession. By what mechanism does Professor Black propose that these surgeons keep a long NHS waiting list? Do they not turn up for work when expected? This hackneyed explanation of long waiting lists is simply a political excuse for failing to provide adequate capacity in the NHS. However, in a publicly funded health service, few taxpayers would countenance a surplus of NHS surgeons sitting around waiting for patients. Far better the alternative-a reasonable wait for publicly funded surgery, and for those who wish to be treated at their convenience, a privately funded option.
